EUR 3.55
(-2.74%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -22.98 Million EUR | -13.69% |
2022 | -20.21 Million EUR | -4.78% |
2021 | -19.29 Million EUR | -50.72% |
2020 | -12.8 Million EUR | -60.24% |
2019 | -7.98 Million EUR | 47.74% |
2018 | -15.28 Million EUR | 11.17% |
2017 | -17.2 Million EUR | -88.85% |
2016 | -9.11 Million EUR | -64.85% |
2015 | -5.52 Million EUR | -14.1% |
2014 | -4.84 Million EUR | -11.42% |
2013 | -4.34 Million EUR | -9.35% |
2012 | -3.97 Million EUR | -8.91% |
2011 | -3.65 Million EUR | -8.03% |
2010 | -3.37 Million EUR | 5.69% |
2009 | -3.58 Million EUR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -12.45 Million EUR | 0.0% |
2023 Q2 | -10.08 Million EUR | 0.0% |
2023 Q4 | -12.89 Million EUR | 0.0% |
2023 FY | -22.98 Million EUR | -13.69% |
2022 Q4 | -11.33 Million EUR | 0.0% |
2022 FY | -20.21 Million EUR | -4.78% |
2022 Q2 | -8.88 Million EUR | 0.0% |
2021 Q4 | -9.78 Million EUR | 0.0% |
2021 FY | -19.29 Million EUR | -50.72% |
2021 Q2 | -9.5 Million EUR | 0.0% |
2020 Q2 | -4.64 Million EUR | 0.0% |
2020 Q4 | -8.16 Million EUR | 0.0% |
2020 FY | -12.8 Million EUR | -60.24% |
2019 Q2 | -4.22 Million EUR | 0.0% |
2019 FY | -7.98 Million EUR | 47.74% |
2019 Q4 | -3.76 Million EUR | 0.0% |
2018 Q4 | -6.32 Million EUR | 0.0% |
2018 FY | -15.28 Million EUR | 11.17% |
2018 Q2 | -8.95 Million EUR | 0.0% |
2017 FY | -17.2 Million EUR | -88.85% |
2017 Q4 | -8.32 Million EUR | 0.0% |
2017 Q2 | -8.88 Million EUR | 0.0% |
2016 FY | -9.11 Million EUR | -64.85% |
2016 Q2 | -3.65 Million EUR | 0.0% |
2016 Q4 | -5.45 Million EUR | 0.0% |
2015 Q2 | -2.47 Million EUR | 0.0% |
2015 FY | -5.52 Million EUR | -14.1% |
2015 Q4 | -3.05 Million EUR | 0.0% |
2014 FY | -4.84 Million EUR | -11.42% |
2014 Q4 | -2.21 Million EUR | 0.0% |
2014 Q2 | -2.26 Million EUR | 0.0% |
2013 Q2 | -2.13 Million EUR | 0.0% |
2013 Q4 | -2.21 Million EUR | 0.0% |
2013 FY | -4.34 Million EUR | -9.35% |
2012 Q4 | - EUR | 0.0% |
2012 FY | -3.97 Million EUR | -8.91% |
2012 Q2 | - EUR | 0.0% |
2011 Q4 | - EUR | 0.0% |
2011 FY | -3.65 Million EUR | -8.03% |
2010 FY | -3.37 Million EUR | 5.69% |
2009 FY | -3.58 Million EUR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Affluent Medical SA | -15.65 Million EUR | -46.822% |
Bluelinea Société Anonyme | -1.62 Million EUR | -1318.642% |
Carmat SA | -53.86 Million EUR | 57.337% |
Diagnostic Medical Systems S.A. | -4.94 Million EUR | -364.658% |
Euromedis Groupe | 13.11 Million EUR | 275.297% |
Eurobio Scientific Société anonyme | 4.83 Million EUR | 575.326% |
Ikonisys S.A. | -2.26 Million EUR | -913.474% |
Implanet S.A. | -6.67 Million EUR | -244.248% |
SpineGuard SA | -4.18 Million EUR | -449.36% |
Theraclion SA | -3.67 Million EUR | -525.36% |
Euroapi S.A. | -189.7 Million EUR | 87.885% |
Guerbet SA | 23.86 Million EUR | 196.296% |
Ion Beam Applications SA | -9.11 Million EUR | -152.272% |
Koninklijke Philips N.V. | -466 Million EUR | 95.068% |
Sequana Medical NV | -32.56 Million EUR | 29.424% |